Test | Test day | Cumulative proportion positive | Efficacy (%) | Comparison | |
---|---|---|---|---|---|
Control | Lotilaner | ||||
Blood smear | 2 | 8/8 | 0/8 | 100 | χ 2 (1) = 16, P = 0.0002 |
14 | 15/16 | 0/8 | 100 | χ 2 (1) = 20, P < 0.0001 | |
Study 1 | 28 | 15/23 | 0/8 | 100 | χ 2 (1) = 10.11, P = 0.0024 |
Study 2 | 28 | 6/6 | 0/6 | 100 | χ 2 (1) = 12, P = 0.0022 |
IFA | 2 | 8/8 | 0/8 | 100 | χ 2 (1) = 16, P = 0.0002 |
14 | 15/16 | 0/8 | 100 | χ 2 (1) = 20, P < 0.0001 | |
Study 1 | 28 | 15/23 | 0/8 | 100 | χ 2 (1) = 10.11, P = 0.0024 |
Study 2 | 28 | 6/6 | 0/6 | 100 | χ 2 (1) = 12, P = 0.0022 |
PCR | 2 | 8/8 | 0/8 | 100 | χ 2 (1) = 16, P = 0.0002 |
14 | 15/16 | 0/8 | 100 | χ 2 (1) = 20, P < 0.0001 | |
Study 1 | 28 | 15/23 | 0/8 | 100 | χ 2 (1) = 10.11, P = 0.0024 |
Study 2 | 28 | 6/6 | 0/6 | 100 | χ 2 (1) = 12, P = 0.0022 |